David Scannell KC

Practice Areas

David is a leading silk in competition law, life sciences (pharma, food and chemicals regulation in the UK and EU) and EU law. He was nominated as Competition Silk of the Year in 2023 and as Barrister of the Year 2025 at the Lawyer Awards.

David’s recent competition cases include Stellantis v Autoliv ([2025] CAT 9) for the successful defendant, Autoliv; Phones 4U v EE, DT, Orange and Others ([2025] EWCA Civ 869 and [2023] EWHC 2826 (Ch)), for the successful defendant, Orange; and Prochlorperazine (2024 CAT 36), for the successful appellant, CinVen. He acts for SalMar in the Salmon Cartel cases, for the Road Haulage Association Used Trucks in the Trucks collective proceedings, for Sun/Ranbaxy in the Lundbeck/Citalopram follow-on and for Epic Games in Epic Games v Google.

David’s recent life-sciences cases include R(Guilin) v Food Standards Agency [2024] EWHC 614 (Admin), a successful judicial review resulting in the reclassification of monk fruit across the UK and the EU; ABOCA (T-302/21, EU:T:2024:808), successfully quashing a Commission Regulation banning hydroxyanthracine derivatives in the EU; Orion Corp v S/S Health ([2019] EWHC 689 (Admin)); and Easynet ([2018] EWCA Civ 10); Symrise v European Chemicals Agency (General Court); AbbVie v European Medicines Agency (General Court and Court of Justice); PTC v European Medicines Agency (General Court and Court of Justice); GE Healthcare v Commission (General Court); Aer Lingus v Commission (General Court); and R(British American Tobacco) v S/S Health (Admin. Court, Court of Justice and Court of Appeal).